IFNG and acute lymphoblastic leukemia: Our finding that only part of the B‐ALL cells upregulates MHC II in response to IFN‐γ may point to intratumor heterogeneity, i.e., the presence of pre‐existing resistant B‐ALL subpopulations that are positively selected under treatment.